Sarah Elizabeth Schellhorn

Sarah Elizabeth Schellhorn is an Associate Professor of Medicine in the Department of Medicine at Yale University, specializing in Medical Oncology with a focus on breast cancer treatment and healthcare policy. She holds leadership roles as Chief of Ambulatory Services and Chief Ambulatory Officer at Smilow Cancer Hospital, overseeing clinical operations and cancer care delivery. Her research centers on chemotherapy regimens, adherence to oral oncology medications, and health policy implications in oncology. She is actively involved in the COPPER Center, exploring public policy and clinical effectiveness in cancer care.

Education:

• BA, Harvard College, 2000
• MD, Weill Cornell Medical College, 2006
• Residency, Beth Israel Deaconess Medical Center, 2009
• Fellowship, MD Anderson Cancer Center, 2013

Research Interests: Dr. Schellhorn investigates breast cancer treatment protocols, particularly in elderly populations, and develops tools to enhance patient adherence to oral therapies. Her work addresses healthcare disparities, oncology practice standards, and the integration of digital health solutions in cancer care.

Key Contributions: She leads the BETA study on text-message-based adherence interventions and collaborates on studies analyzing treatment bias, telemedicine for community oncologists, and cost-effectiveness of neoadjuvant therapies.

Awards:

• David S. Fischer Teaching Award (2016, 2019)
• Quality Care Symposium Merit Award (2012)
• Clifton Howe Award (2011)

Leadership & Service: Co-Chairs Smilow’s Central Shoreline Planning Committee and Ambulatory Transformation Steering Committee. Active in ASCO and serves on SWOG’s Digital Engagement Committee. Committed to improving access to cancer care through policy and operational innovations.